October 10, 2016 / 11:02 PM / 10 months ago

BRIEF-3Sbio updates on license agreement with Astrazeneca

Oct 11 (Reuters) - 3sbio

* Updates on exclusive License Agreement With Astrazeneca in respect of Byetta And Bydureon

* Astrazeneca has agreed to grant an exclusive license to Hongkong Sansheng

* Hongkong sansheng, a wholly-owned subsidiary of company, as licensee, entered into exclusive license agreement with Astrazeneca

* License for commercialization of licensed products in PRC

* Hongkong Sansheng has agreed to pay an upfront payment of us$50 million

* Parties have agreed that astrazeneca will supply licensed products and licensee will pay astrazeneca pre-agreed purchase price of licensed products Source text for Eikon: Further company coverage: (Bengaluru Newsroom; +1 646 223 8780; )

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below